Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T May

Showing results (801-810 of 817) with videos related to

Pageof 82
Sort By:
International Journal of Epidemiology|November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret T May, Robert S Hogg, Amy C Justice, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
European Journal of Heart Failure|May 15, 2022
Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failureMintu Nath, Simon P R Romaine, Andrea Koekemoer, et al.
International Journal of Epidemiology|April 20, 2013
Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)Margaret T May, Suzanne M Ingle, Dominique Costagliola, et al.
AIDS (London, England)|May 31, 2013
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009Sophie Abgrall, Suzanne M Ingle, Margaret T May, et al.
The Lancet. Global Health|February 23, 2020
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysisAaron G Lim, Josephine G Walker, Nyashadzaishe Mafirakureva, et al.
Nature|September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesiaChristopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Journal of the International AIDS Society|January 16, 2018
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiationApril C Pettit, Mark J Giganti, Suzanne M Ingle, et al.
Pageof 82

Showing results (801-810 of 817) with videos related to

Sort By:
Pageof 82
International Journal of Epidemiology|November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret T May, Robert S Hogg, Amy C Justice, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
European Journal of Heart Failure|May 15, 2022
Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failureMintu Nath, Simon P R Romaine, Andrea Koekemoer, et al.
International Journal of Epidemiology|April 20, 2013
Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)Margaret T May, Suzanne M Ingle, Dominique Costagliola, et al.
AIDS (London, England)|May 31, 2013
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009Sophie Abgrall, Suzanne M Ingle, Margaret T May, et al.
The Lancet. Global Health|February 23, 2020
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysisAaron G Lim, Josephine G Walker, Nyashadzaishe Mafirakureva, et al.
Nature|September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesiaChristopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Journal of the International AIDS Society|January 16, 2018
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiationApril C Pettit, Mark J Giganti, Suzanne M Ingle, et al.
Pageof 82